Indeed, downregulation or recurrent SAMHD1 mutations were found in some cancer entities like chronic lymphocytic leukemia, colon cancer and T-cell prolymphocytic leukemia and were particular increased in chemorefractory cases, which classifies SAMHD1 as cancer gene (13,30,35,36). Here, SAMHD1 is linked to T-cell prolymphocytic leukemia.